Previous Article | Next Article ![]()
Infection and Immunity, March 2000, p. 1740-1745, Vol. 68, No. 3
Departamento de Microbiología,
Facultad de Medicina,1 Unidad de
Investigación, Hospital Clínico
Universitario,2 and Instituto de
Biología y Genética Molecular, Consejo Superior de
Investigaciones Cientificas,3 Valladolid, Spain
Received 28 October 1999/Returned for modification 16 November
1999/Accepted 6 December 1999
Smooth lipopolysaccharide (S-LPS) and lipid A of Brucella
abortus and Brucella melitensis induced the
production of nitric oxide (NO) by rat adherent peritoneal cells, but
they induced lower levels of production of NO than Escherichia
coli LPS. The participation of the inducible isoform of NO
synthase (iNOS) was confirmed by the finding of an increased expression
of both iNOS mRNA and iNOS protein. These observations might help to
explain (i) the acute outcome of Brucella infection in
rodents, (ii) the low frequency of septic shock in human brucellosis,
and (iii) the prolonged intracellular survival of Brucella
in humans.
Members of the genus
Brucella are gram-negative bacteria that produce chronic
infections in a large number of mammals, including humans
(10). Brucella species are facultative
intracellular pathogens which survive within a variety of cells,
including macrophages, and the virulence of these species and the
establishment of chronic infections by them are thought to be
essentially due to their ability to avoid the killing mechanisms within
macrophages (3, 36). The molecular mechanisms accounting for
these properties are incompletely understood, and only some aspects of
the processes involved have been identified as yet. Brucella
does not evade phagocytosis by macrophages or neutrophils
(6) but inhibits the degranulation of both primary and
secondary neutrophil granules (30, 33, 34) and the
myeloperoxidase-hydrogen peroxide-halide system (5, 7). The
virulence of Brucella abortus, Brucella melitensis, and Brucella suis is associated with the
smooth colony morphotype which contains the full lipopolysaccharide
(LPS) (36, 38). The low biological activity induced by
Brucella smooth LPS (S-LPS) compared with that produced by
enterobacterial endotoxin might be one of the factors contributing to
the survival of these pathogens in phagocytic cells (32).
Further, a major proportion of the protective antibody response is
directed against the O-chain component of the S-LPS (11) and
Brucella LPS itself is a virulent factor because it is the
main cause of the resistance of Brucella to lysosomal
cationic proteins (15).
Nitric oxide (NO) has been shown to play an important role in diverse
functions, including vasoregulation, neurotransmission, immune response
regulation (23, 24, 37), and macrophage-mediated cytotoxic
activity against tumor cells and a variety of pathogens, including
bacteria, fungi, viruses, helminths, and protozoa (22). NO
has been implicated in host defenses against intracellular pathogens
and might play a role in persistent or latent infections (14). NO is derived from L-arginine in a
reaction catalyzed by the enzyme NO synthase (NOS), of which three
different isoforms have been identified (29). The inducible
isoform of NOS (iNOS) is responsible for the high-output path of NO
production involved in antimicrobial activity (28). iNOS
expression is induced by proinflammatory cytokines such as gamma
interferon (IFN- Pathogen-free Wistar rats (200 to 300 g) were used for all
studies. B. melitensis 16M (biotype 1) and B. abortus 544 (biotype 1) smooth virulent strains were grown on
Brucella broth (Difco Laboratories, Detroit, Mich.).
Phenol-inactivated bacteria were harvested by centrifugation and washed
twice with saline. S-LPS was extracted by the phenol-water method
modified for Brucella organisms as described by Leong et al.
(20), which allows the separation of Brucella
S-LPS in the phenolic phase. Purification of crude S-LPS isolated in
the phenolic phase was performed according to the procedure of Moreno
et al. (26). The thiobarbituric method was used to measure
2-keto-3-deoxyoctonate (KDO) (2). Under these experimental
conditions B. melitensis 16M purified S-LPS contained 0.79%
KDO, B. abortus 544 purified S-LPS contained 0.70% KDO, and
E. coli O:26,B:6 LPS (Sigma Chemical, St. Louis, Mo.) contained 1.6% KDO. Lipid A from E. coli, B. abortus, and B. melitensis was obtained by hydrolysis
of purified S-LPS with 2% acetic acid at 100°C for 1 h
(E. coli) or 5 h (Brucella) (25).
Resident peritoneal cells were collected from the peritoneal cavity
with cold phosphate-buffered saline as reported previously
(4). Adherent macrophage monolayers were obtained by plating
the cells in 24-well tissue culture plates at 1.5 × 106 cells/well for 2 h at 37°C. The production of NO
was determined by the accumulation of nitrite measured by the Griess
reaction (16). Statistical analysis was carried out using
the unpaired Student t test for comparison of two means and
one-way analysis of variance with the Bonferroni test for multiple
comparisons of means. Statistical significance was set at a
P value of <0.05.
Production of NO by rat peritoneal cells stimulated
Brucella S-LPS and lipid A.
Peritoneal cells
stimulated with E. coli, B. abortus, and B. melitensis LPS generated nitrite in a dose-dependent manner (Fig. 1A). Since E. coli LPS is a
microbial product inducing NO production by murine macrophages
(39), it was included as a control of our cellular system
and for comparison with Brucella S-LPS induction. E. coli LPS induced a significant level of production of NO from a
dose of 0.01 µg/ml, plateau values being reached for LPS doses of
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Lipopolysaccharides of Brucella abortus
and Brucella melitensis Induce Nitric Oxide Synthesis in Rat
Peritoneal Macrophages
![]()
ABSTRACT
Top
Abstract
Text
References
![]()
TEXT
Top
Abstract
Text
References
), tumor necrosis factor alpha, and interleukin 1 (IL-1), as well as by microbial products such as LPS and lipoteichoic
acid (14). The purpose of this study was to determine
whether Brucella S-LPS induces NO production in rat
peritoneal macrophages and compare the effects of S-LPS from various
Brucella species with that of Escherichia coli
LPS. Since most biological effects of LPS have been associated with the
lipid A moiety (25), we also investigated NO induction by
Brucella lipid A. We report that B. abortus and B. melitensis S-LPS and lipid A induce NO production in rat
peritoneal macrophages by a mechanism involving transcriptional
up-regulation of the iNOS gene.
1
µg/ml. B. abortus S-LPS showed significant levels of NO production at doses of >0.1 µg/ml and produced maximal levels at a
dose of 10 µg/ml. B. melitensis S-LPS induced NO
production at concentrations higher than 0.01 µg/ml, with maximal
induction at doses of
1 µg/ml. These data indicate that E. coli LPS is the most potent inductor of NO, whereas there was no
significant difference in the NO production levels induced by B. abortus and B. melitensis S-LPS. The generation of
nitrite by E. coli, B. abortus, and B. melitensis LPS was time dependent (Fig. 1B), first showing a lag
of
8 h before significant production could be assayed and then
increasing up to 24 h and showing plateau levels at 48 and 72 h (data not shown). Because most of the biological effects of the LPS
have been associated with the lipid A moiety, we studied the ability of
these lipids to induce NO production. Lipid A from both
Brucella stimulated the production of NO in a dose-dependent manner (Fig. 1C). E. coli lipid A was again a potent
inductor, significant production of NO being detected with
concentrations of lipid A as low as 0.001 µg/ml, whereas maximal
production was observed at a concentration of
0.1 µg/ml. B. abortus and B. melitensis lipid A showed similar
potencies to elicit NO induction, i.e., significant amounts of nitrite
were obtained in the presence of a concentration of 0.1 µg/ml and
maximal production was obtained with concentrations of
1 µg/ml.
Evidence of the involvement of the L-arginine pathway was
obtained with the NOS inhibitor
NG-methyl-L-arginine
(L-NMA), which suppressed nitrite production induced by
each LPS and lipid A (Fig. 2).

View larger version (18K):
[in a new window]
FIG. 1.
(A) Production of nitrite by rat peritoneal adherent
cells stimulated with different concentrations of E. coli
LPS (
), B. abortus S-LPS (
), and B. melitensis S-LPS (
). Adherent rat peritoneal cells were
stimulated with LPS at the concentrations indicated.
NO2
production was assayed 24 h after
stimulation. Data are the means ± the standard errors of the
means of results of four experiments with duplicate samples. (B)
Kinetics of nitrite synthesis by adherent peritoneal cells stimulated
with 1 µg of E. coli LPS (
), B. abortus
S-LPS (
), or B. melitensis S-LPS (
) per ml. Cells were
allowed to adhere to plastic dishes and then were stimulated as
indicated. Open circles indicate cells without any stimulus. Data are
the means ± the standard errors of the means of results of three
experiments performed in duplicate. (C) Production of nitrite by rat
peritoneal adherent cells stimulated with different concentrations of
E. coli (
), B. abortus (
), or B. melitensis (
) lipid A. Nitrite production was assayed after
24 h of incubation. Data are the means ± the standard errors
of the means of results of four experiments with duplicate samples. The
nitrite levels induced by Brucella S-LPS and lipid A were
significantly different from those of E. coli. *,
P < 0.05; **, P < 0.01;
***, P < 0.001.

View larger version (33K):
[in a new window]
FIG. 2.
Effect of L-NMA on nitrite production
induced by E. coli, B. abortus, and B. melitensis LPS and lipid A. Adherent cells were incubated with 1 µg of the indicated LPS (A) or lipid A (B) per ml, in the presence
(solid bars) or absence (hatched bars) of 0.5 mM L-NMA.
Nitrite production was assayed after 24 h. Open bars show the
production by control cells. Data are the means ± the standard
errors of the means of results of three experiments performed in
duplicate. The nitrite levels induced in the presence of
L-NMA were significantly different from those induced with
only the LPS or lipid A. *, P < 0.001.
Induction of iNOS mRNA expression in adherent peritoneal cells
stimulated with LPS and lipid A.
To address the involvement of
iNOS in response to Brucella S-LPS the expression of iNOS
mRNA was studied by Northern blot analysis. For this purpose, total
cellular RNA was prepared from cell cultures according to the guanidium
isothiocyanate method (8). Aliquots of total RNA (10 µg)
were denatured and then separated by electrophoresis (35).
After capillary transference of the RNA to nylon membranes, the
membranes were hybridized overnight (9) with a radiolabeled
DNA probe specific for mouse macrophage iNOS. The membranes were
rehybridized, with 32P-labeled
-actin probe used as an
internal control to demonstrate the integrity of the RNA, the
equivalence of loading, and the specificity of mRNA induction. As shown
in Fig. 3, cells incubated with E. coli, B. abortus, and B. melitensis LPS
showed enhanced expression of iNOS mRNA compared to cells incubated
with vehicle. E. coli LPS induced an increased expression of
iNOS mRNA that was already detected at 2 h and that showed a peak
at 8 h and an elevation above resting levels at 24 h (Fig.
4A and B). This time course of iNOS mRNA
induction closely parallels nitrite production. B. abortus
S-LPS also showed a time-dependent induction of iNOS mRNA (Fig. 4C and
D), with increased levels after 2 h of stimulation and a maximal
expression at 4 h. Incubation with B. melitensis S-LPS
also increased iNOS mRNA in a time-dependent manner (Fig. 4E and F).
Nitrite production induced by lipid A also correlated with iNOS mRNA
expression. As shown in Fig. 3, the addition of E. coli,
B. abortus, and B. melitensis lipid A enhanced
iNOS mRNA expression, thus confirming the involvement of the lipid A
moiety in this biological effect. Induction of iNOS mRNA was
accompanied by the expression of iNOS protein, as judged from Western
blot analysis. For this purpose, cell lysates were subjected to
electrophoresis on a sodium dodecyl sulfate-8% polyacrylamide gel,
transferred to a nitrocellulose membrane, and then incubated with
rabbit anti-mouse iNOS antibody (Calbiochem). The detection was
performed using the enhanced chemiluminescence system (Amersham).
Figure 5 shows the expression of iNOS
protein in adherent peritoneal cells incubated with 10 µg of LPS from
either class per ml.
|
|
|
100-fold less potent than
E. coli lipid A, a result in agreement with the relative potency reported by Rasool et al. (32), who compared the
effect of Brucella and Salmonella LPS on
nitroblue tetrazolium reduction and lysozyme release by neutrophils.
Since NO is a potent vasodilator, the overproduction of which has been
shown to occur during the host inflammatory response associated with
septic shock (13, 31), the reduced ability of
Brucella S-LPS to induce NO production could explain the low frequency of septic shock and multiorgan failure observed in
brucellosis (19) and the occurrence of clinical episodes
similar to those observed upon infusion of small amounts of endotoxin
(40). However, before extending these results to
pathophysiological conditions, it should be taken into account that
peritoneal macrophages are not the only contributors to host response
during endotoxin-induced injury in vivo and the in vitro approach may
overlook the contribution of other major players acting in vivo
(1).
Expression of iNOS mRNA in J774A.1 cells infected with B. suis has been reported; however, both iNOS protein and NO
production were detected only upon treatment with IFN-
and
antibrucella-specific antibodies (17). Since the stimulation
of receptors for the Fc portion of immunoglobulin G (Fc
R) can induce
iNOS expression in rat macrophages (4), and immune complexes
of different isotypes increase nitrite levels in murine macrophage-like
J774.16 cells treated with IFN-
(27), it seems likely
that stimulation of Fc
R could be the mechanism accounting for the
induction of iNOS under these conditions. The synergistic inductive
contribution of IFN-
(17) agrees with the current
paradigm of transcriptional regulation of iNOS. In fact, two regions
have been identified in the promoter region of the mouse gene for
macrophage iNOS (21): region I contains LPS-related
responsive elements, including a binding site for nuclear factor-IL-6
and the
B binding site for activation of NF-
B, and region II
contains motifs for binding IFN-related transcription factors such as
interferon regulatory factor-1. Since NF-
B is involved in the
induction of iNOS by LPS (43) and Fc
R (4),
these findings show the high degree of functional cooperation between
microbial components and host immune response in the induction of the
transcriptional activation implicated in antimicrobial actions.
Evidence of NO-dependent antimicrobial activity by human macrophages
against parasites, fungi, bacteria, and viruses is now available
(41), although significant differences between murine macrophages and human monocytes or macrophages have been stressed (12). Whereas rodent macrophages respond vigorously to a
combination of IFN-
and LPS, these stimuli induce the expression of
iNOS in human cells but do not elicit any production of nitrogen
derivatives, suggesting posttranslational regulation of NO synthesis in
human cells (42). Addressing the effect of NO on
Brucella survival seems of interest since
Brucella stays alive in phagocytic cells; however, this is a
controversial issue as yet. Zhan et al. (45) showed a
vigorous production of NO by spleen cells of B. abortus-infected mice, compared to that of both spleen cells from
noninfected mice and spleen cells from IL-12-depleted mice. When
heat-killed brucellae were used as a stimulus for spleen cells from
B. abortus-infected mice, the culture supernatants contained
higher levels of nitrite than those for which an unrelated antigen was
used (44). This could be explained by the activating effect
of IFN-
on NO production, but this could also be accounted for by
the induction of NO by brucella LPS. The involvement of NO in the
antibrucella activities of macrophages has also been suggested by
pharmacological experiments with L-NMA (18),
since this treatment increased significantly the number of brucellae
recovered from macrophages infected with B. abortus isolated
from the peritoneal cavity. However, when L-NMA was added
to macrophages activated with IFN-
prior to the infection with
brucellae, a decrease of the number of CFU was observed, thus
suggesting that NO might down-regulate the production of reactive
oxygen intermediates. A corollary to these findings is that reactive
oxygen intermediates might play a major role in antibrucella
activities, whereas NO plays a minor one. In contrast, a direct killing
of B. suis by NO and an increase of the intracellular development of Brucella by iNOS inhibitors in
IFN-
-treated J774A.1 cells infected with B. suis have
been reported (17). In summary, B. abortus and
B. melitensis S-LPS induce NOS in rat peritoneal macrophages. The ensuing NO production could explain why
Brucella infection is controlled in mice, unlike human
brucellosis, which tends to be chronic. The low Brucella
S-LPS and lipid A NO production observed at low concentrations compared
with LPS and lipid A E. coli induction could explain the low
frequency of septic shock in human brucellosis and could contribute to
explaining the long intracellular survival of Brucella.
| |
ACKNOWLEDGMENTS |
|---|
We thank I. Moriyón, from the University of Navarra, for performing the KDO assays of LPS.
This work was supported by grants FIS 96/1017, SAF96-0144, and SAF98-0176.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: IBGM, Facultad de Medicina, 47005-Valladolid, Spain. Phone: 34-983-423273. Fax: 34-983-423588. E-mail: mscres{at}ibgm.uva.es.
Editor: E. I. Tuomanen
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Amura, C. R.,
R. Silverstein, and D. C. Morrison.
1998.
Mechanisms involved in the pathogenesis of sepsis are not necessarily reflected by in vitro cell activation studies.
Infect. Immun.
66:5372-5378 |
| 2. |
Aragón, V.,
R. Díaz,
E. Moreno, and I. Moriyón.
1996.
Characterization of Brucella abortus and Brucella melitensis native haptens as outer membrane O-type polysaccharides independent from the smooth lipopolysaccharide.
J. Bacteriol.
178:1070-1079 |
| 3. | Baldwin, C. L., and A. J. Winter. 1994. Macrophages and Brucella. Immunol. Ser. 60:363-380[Medline]. |
| 4. |
Bayón, Y.,
A. Alonso, and M. Sánchez Crespo.
1997.
Stimulation of Fc receptors in rat peritoneal macrophages induces the expression of nitric oxide synthase and chemokines by mechanisms showing different sensitivities to antioxidants and nitric oxide donors.
J. Immunol.
159:887-894[Abstract].
|
| 5. | Berman, D. T., and R. S. Kurtz. 1987. Relationship of biological activities to structures of Brucella abortus endotoxin and LPS. Ann. Inst. Pasteur Microbiol. 138:98-101[CrossRef][Medline]. |
| 6. | Canning, P. C. 1990. Phagocyte function in resistance to brucellosis, p. 151-163. In L. G. Adams (ed.), Advances in brucellosis research. Texas A&M University Press, College Station. |
| 7. | Canning, P. C., J. A. Roth, and B. L. Deyoe. 1986. Release of 5'-guanosine monophosphate and adenine by Brucella abortus and their role in the intracellular survival of the bacteria. J. Infect. Dis. 154:464-470[Medline]. |
| 8. | Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156-159[Medline]. |
| 9. |
Church, G. M., and W. Gilbert.
1984.
Genomic sequencing.
Proc. Natl. Acad. Sci. USA
81:1991-1995 |
| 10. | Corbel, M. J., and W. J. Brinley-Morgan. 1984. Genus Brucella Meyer and Shaw 1920, 173AL, p. 377-388. In N. R. Krieg, and J. G. Holt (ed.), Bergey's manual of systematic bacteriology, vol. 1. Williams & Wilkins, Baltimore, Md. |
| 11. |
Díaz, R.,
L. M. Jones,
D. Leong, and J. B. Wilson.
1968.
Surface antigens of smooth brucellae.
J. Bacteriol.
96:893-901 |
| 12. | Dugas, B., P. Debre, and S. Moncada. 1995. Nitric oxide, a vital poison inside the immune and inflammatory network. Res. Immunol. 146:664-670[CrossRef][Medline]. |
| 13. | English, B. K., C. C. Patrick, S. L. Orlicek, R. McCordic, and J. L. Shenep. 1996. Lipoteichoic acid from viridans streptococci induces the production of tumor necrosis factor and nitric oxide by murine macrophages. J. Infect. Dis. 174:1348-1351[Medline]. |
| 14. | Fang, F. C. 1997. Perspectives series: host/pathogen interactions. Mechanisms of nitric oxide-related antimicrobial activity. J. Clin. Investig. 99:2818-2825[Medline]. |
| 15. |
Freer, E.,
E. Moreno,
I. Moriyón,
J. Pizarro-Cerdá,
A. Weintraub, and J. P. Gorvel.
1996.
Brucella-Salmonella lipopolysaccharide chimeras are less permeable to hydrophobic probes and more sensitive to cationic peptides and EDTA than are their native Brucella sp. counterparts.
J. Bacteriol.
178:5867-5876 |
| 16. | Green, L. C., D. A. Wagner, J. Glogowski, P. L. Skipper, J. S. Wishnok, and S. R. Tannenbaum. 1982. Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal. Biochem. 126:131-138[CrossRef][Medline]. |
| 17. |
Gross, A.,
S. Spiesser,
A. Terraza,
B. Rouot,
E. Caron, and J. Dornand.
1998.
Expression and bactericidal activity of nitric oxide synthase in Brucella suis-infected murine macrophages.
Infect. Immun.
66:1309-1316 |
| 18. | Jiang, X., B. Leonard, R. Benson, and C. L. Baldwin. 1993. Macrophage control of Brucella abortus: role of reactive oxygen intermediates and nitric oxide. Cell. Immunol. 151:309-319[CrossRef][Medline]. |
| 19. | Kress, S., P. Klooker, V. Kaufmann, N. Sloot, J. F. Riemann, and H. Brass. 1997. Brucellosis with fatal endotoxic shock. Med. Klin. 92:561-566[Medline]. |
| 20. |
Leong, D.,
R. Díaz,
K. Milner,
J. Rudbach, and J. B. Wilson.
1970.
Some structural and biological properties of Brucella endotoxin.
Infect. Immun.
1:174-182 |
| 21. |
Lowenstein, C. J.,
E. W. Alley,
P. Raval,
A. M. Snowman,
S. H. Snyder,
S. W. Russell, and W. J. Murphy.
1993.
Macrophage nitric oxide synthase gene: two upstream regions mediate induction by interferon- and lipopolysaccharide.
Proc. Natl. Acad. Sci. USA
90:9730-9734 |
| 22. | MacMicking, J., Q. W. Xie, and C. Nathan. 1997. Nitric oxide and macrophage function. Annu. Rev. Immunol. 15:323-350[CrossRef][Medline]. |
| 23. |
Moncada, S., and A. Higgs.
1993.
The L-arginine-nitric oxide pathway.
N. Engl. J. Med.
329:2002-2012 |
| 24. | Moncada, S., R. M. Palmer, and E. A. Higgs. 1991. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 43:109-142[Medline]. |
| 25. |
Moreno, E.,
D. T. Berman, and L. A. Boettcher.
1981.
Biological activities of Brucella abortus lipopolysaccharides.
Infect. Immun.
31:362-370 |
| 26. |
Moreno, E.,
M. W. Pitt,
L. M. Jones,
G. G. Schurig, and D. T. Berman.
1979.
Purification and characterization of smooth and rough lipopolysaccharides from Brucella abortus.
J. Bacteriol.
138:361-369 |
| 27. |
Mozaffarian, N.,
J. W. Berman, and A. Casadevall.
1995.
Immune complexes increase nitric oxide production by interferon- stimulated murine macrophage-like J774.16 cells.
J. Leukoc. Biol.
57:657-662[Abstract].
|
| 28. | Nathan, C. 1997. Inducible nitric oxide synthase: what difference does it make? J. Clin. Investig. 100:2417-2423[Medline]. |
| 29. | Nathan, C., and Q. W. Xie. 1994. Nitric oxide synthases: roles, tolls, and controls. Cell 78:915-918[CrossRef][Medline]. |
| 30. | Orduña, A., C. Orduña, J. M. Eiros, M. A. Bratos, P. Gutiérrez, P. Alonso, and T. A. Rodríguez. 1991. Inhibition of the degranulation and myeloperoxidase activity of human polymorphonuclear neutrophils by Brucella melitensis. Microbiologia 7:113-119[Medline]. |
| 31. |
Parrillo, J. E.
1993.
Pathogenetic mechanisms of septic shock.
N. Engl. J. Med.
328:1471-1477 |
| 32. |
Rasool, O.,
E. Freer,
E. Moreno, and C. Jarstrand.
1992.
Effect of Brucella abortus lipopolysaccharide on oxidative metabolism and lysozyme release by human neutrophils.
Infect. Immun.
60:1699-1702 |
| 33. |
Riley, L. K., and D. C. Robertson.
1984.
Ingestion and intracellular survival of Brucella abortus in human and bovine polymorphonuclear leukocytes.
Infect. Immun.
46:224-230 |
| 34. | Robertson, D. C., L. K. Riley, and D. L. Kreutzer. 1979. Intracellular survival of smooth and rough strains of Brucella, p. 150-153. In D. Schlessinger (ed.), Microbiology. American Society for Microbiology, Washington, D.C. |
| 35. | Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed., p. 7.1-7.78. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y. |
| 36. | Sangari, F. J., and J. Agüero. 1996. Molecular basis of Brucella pathogenicity: an update. Microbiologia 12:207-218[Medline]. |
| 37. | Schmidt, H. H., and U. Walter. 1994. NO at work. Cell 78:919-925[CrossRef][Medline]. |
| 38. | Smith, L. D., and T. A. Ficht. 1990. Pathogenesis of Brucella. Crit. Rev. Microbiol. 17:209-230[Medline]. |
| 39. |
Stuehr, D. J., and M. A. Marletta.
1987.
Induction of nitrite/nitrate synthesis in murine macrophages by BCG infection, lymphokines, or interferon- .
J. Immunol.
139:518-525[Abstract].
|
| 40. | Vedder, H., W. Schreiber, A. Yassouridis, S. Gudewill, C. Galanos, and T. Pollmacher. 1999. Dose-dependence of bacterial lipopolysaccharide (LPS) effects on peak response and time course of the immune-endocrine host response in humans. Inflamm. Res. 48:67-74[Medline]. |
| 41. | Vouldoukis, I., D. Mazier, P. Debre, and M. D. Mossalayi. 1995. Nitric oxide and human infectious diseases. Res. Immunol. 146:689-692[CrossRef][Medline]. |
| 42. |
Weinberg, J. B.,
M. A. Misukonis,
P. J. Shami,
S. N. Mason,
D. L. Sauls,
W. A. Dittman,
E. R. Wood,
G. K. Smith,
B. McDonald, and K. E. Bachus.
1995.
Human mononuclear phagocyte inducible nitric oxide synthase (iNOS): analysis of iNOS mRNA, iNOS protein, biopterin, and nitric oxide production by blood monocytes and peritoneal macrophages.
Blood
86:1184-1195 |
| 43. |
Xie, Q. W.,
Y. Kashiwabara, and C. Nathan.
1994.
Role of transcription factor NF- B/Rel in induction of nitric oxide synthase.
J. Biol. Chem.
269:4705-4708 |
| 44. | Zhan, Y., and C. Cheers. 1995. Endogenous interleukin-12 is involved in resistance to Brucella abortus infection. Infect. Immun. 63:1387-1390[Abstract]. |
| 45. |
Zhan, Y.,
Z. Liu, and C. Cheers.
1996.
Tumor necrosis factor- and interleukin-12 contribute to resistance to the intracellular bacterium Brucella abortus by different mechanisms.
Infect. Immun.
64:2782-2786[Abstract].
|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|